MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner
As far as biological branding goes, it’s hard to beat natural killer cells.
These immune responders earned their moniker in the ’70s for their apparent ability to kill viruses and some tumor cells quickly and without initial training. And in recent years, as scientists began re-engineering T cells to attack evasive tumors and creating the first CAR-T treatments, researchers started seriously exploring how to do the same with natural killers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.